Evaluation of low‐dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles